Total Funding
62
61
Total FundingVenture - Series Unknown raised
Growth Score
-15 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
17311
Healx is a rare disease biotechnology company that uses generative AI for drug discovery.
- Tim Guilliams: Co-founder and CEOPast Role: Cambridge Rare Disease Network, Founding Director and Trustee
- Ian Roberts: Director of Therapeutic Technology
About the Company
Healx is a rare disease biotechnology company that uses generative AI for drug discovery. Healx utilizes advanced artificial intelligence (AI) and machine learning technologies to identify potential drug candidates and repurpose existing drugs for new therapeutic applications. By focusing on drug repurposing, Healx aims to find new uses for
existing medications, leveraging their known safety profiles and reducing the risk and cost associated with developing new drugs from scratch.
